Andrew G. Reaume,Michael S. Saporito,Alexander R. Ochman,Christopher K. Lipinski
申请号：
US12495857
公开号：
US08552184B2
申请日:
2009.07.01
申请国别(地区):
US
年份:
2013
代理人:
摘要：
The present invention relates to compounds and pharmaceutically acceptable salts thereof, and compositions comprising the same, that are useful in modulating lyn kinase activity, treating obesity, type II diabetes, metabolic syndrome, and in reducing blood glucose level, weight gain, or fat depot level, or treating a disease or condition associated with the same.
